Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helle Lynggaard

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|August 8, 2024
Helle Lynggaard, Oliver N Keene, Tobias Mütze, et al.
Current Medical Research and Opinion|September 3, 2014
The SimpleMix study with biphasic insulin aspart 30: a randomized controlled trial investigating patient-driven titration versus investigator-driven titrationYan Gao, Cecilia Luquez, Helle Lynggaard, et al.
BMC Medicine|July 27, 2023
Why estimands are needed to define treatment effects in clinical trialsOliver N Keene, Helle Lynggaard, Stefan Englert, et al.
British Journal of Clinical Pharmacology|November 26, 2024
Applying the estimand framework to clinical pharmacology trials with a case study in bioequivalenceHelle Lynggaard, Sue McKendrick, Mark Baird, et al.
Trials|August 19, 2022
Principles and recommendations for incorporating estimands into clinical study protocol templatesHelle Lynggaard, James Bell, Christian Lösch, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 11, 2006
Parent and health professional perspectives in the management of adolescents with diabetes: development of assessment instruments for international studiesHilary Hoey, Hannah M McGee, Michael Fitzgerald, et al.
European Journal of Pediatrics|December 18, 2002
Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study groupReinhard W Holl, Peter G F Swift, Henrik B Mortensen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|August 8, 2024
Helle Lynggaard, Oliver N Keene, Tobias Mütze, et al.
Current Medical Research and Opinion|September 3, 2014
The SimpleMix study with biphasic insulin aspart 30: a randomized controlled trial investigating patient-driven titration versus investigator-driven titrationYan Gao, Cecilia Luquez, Helle Lynggaard, et al.
BMC Medicine|July 27, 2023
Why estimands are needed to define treatment effects in clinical trialsOliver N Keene, Helle Lynggaard, Stefan Englert, et al.
British Journal of Clinical Pharmacology|November 26, 2024
Applying the estimand framework to clinical pharmacology trials with a case study in bioequivalenceHelle Lynggaard, Sue McKendrick, Mark Baird, et al.
Trials|August 19, 2022
Principles and recommendations for incorporating estimands into clinical study protocol templatesHelle Lynggaard, James Bell, Christian Lösch, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 11, 2006
Parent and health professional perspectives in the management of adolescents with diabetes: development of assessment instruments for international studiesHilary Hoey, Hannah M McGee, Michael Fitzgerald, et al.
European Journal of Pediatrics|December 18, 2002
Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study groupReinhard W Holl, Peter G F Swift, Henrik B Mortensen, et al.
Pageof 1